| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |